Skip to content
Company Analysis

Johnson & Johnson JNJ

A comprehensive view of key metrics, scores, and financial health for Johnson & Johnson

Overview of Johnson & Johnson

JNJ NYQ
Healthcare Drug Manufacturers - General Framework: Pharma / Mature Biotech Mega Cap
Johnson & Johnson (JNJ), is a Mega Cap company, in the Drug Manufacturers - General industry, last closed at $269.12, about 64.2% overvalued vs fair value, +51.1% 1Y return, ranked 516/1145 in sector.
Metrics P/E 18.8× Rev Growth 6.1% ROE 35.0% Gross Margin 67.9% Div Yield 2.48%
USD 269.12
-2.22%
(Delayed)
• Vol 90d: 23.9%
52-Week Range
Market Cap
$623.71B
Enterprise Value
$652.32B
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Weak
Health
Fair
Efficiency
Weak
Valuation
Good
Growth
Fair
Profitability
Weak
Health
Fair
Efficiency
Weak
Valuation
Good
Completeness: 100%
Confidence: 62%
Updated: Sep 12
Top Beats
No strong beats yet

Quick Facts

Website https://www.jnj.com
HQ New Brunswick, NJ
Employees 138,200
Fiscal year Dec 31

Next Events

Earnings Oct 13

Fair Value Snapshot

Bear Base Bull
$89
$96
$104
Current: $269.12 -64% vs base

Engine Room Money Flow™

Mega Cap

Pharmaceutical / Mature Biotech - Where revenue goes and how value is created

Flow Steps
Total Revenue
$94.2B
6%%
Gross Profit
$63.9B
4.2%%
R&D Expense
$14.7B
-14.9%%
Operating Income (EBIT)
$33.6B
92.4%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Pharmaceutical / Mature Biotech

Quality & Reliability Indicators

Cash Conversion
73.1%
Fair

Moderate cash conversion - some working capital drag

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$18.3B
94.9% of FCF

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
0/2
Improving
0
High Impact
1
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating Johnson & Johnson's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
66
/100
Moderate
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Margins Stable Across Cycles Operating margin volatility is low (stability score 1.00), demonstrating pricing resilience across cycles.
  • Strong Interest Coverage & Conservative Leverage Debt serviceability is strong (score 1.00), with robust interest coverage.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Strong
76
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 93% Coverage
Trade-Off Triangle Visualization A ternary plot showing JNJ's balance between Growth (32.2%), Profitability (41.9%), and Safety (25.9%). Growth 32% Safety 26% Profitability 42%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

65th percentile vs peers
66
Key Signals
Rev Growth YoY 6.0% 57p EPS Growth YoY 90.6% 75p Revenue CAGR 3Y 5.6% 57p EPS CAGR 3Y 17.9% 74p TSR 46.7% 78p
Strengths
  • Interest Coverage Ratio in top 20% of peers (34.55, 98th percentile)
  • Superior capital returns - 2 return metrics above peer median
  • Growth above peer median with strong metric coverage (100%)
  • Operating Margin in top 20% of peers (27.2%, 89th percentile)
Risks

No significant risks identified for this axis.

Profitability

85th percentile vs peers
85
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

52th percentile vs peers
53
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Johnson & Johnson.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$96.42
- - -
-64.2% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000